Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Lisle M. Nabell is a leading oncologist and researcher whose work centers on head and neck cancers, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCC). Her major contributions lie at the intersection of surgical innovation and molecular imaging, most notably in developing fluorescence-guided surgery using panitumumab-IRDye800CW. In her landmark 2024 study, she demonstrated how this targeted imaging agent can enhance transoral robotic surgery (TORS) by improving tumor visualization and margin assessment, addressing the critical challenge of limited tactile feedback in robotic procedures. This work, cited 15 times in its first year, has significant implications for improving surgical precision and patient outcomes. Dr. Nabell’s research bridges the gap between oncology and surgical technique, offering new strategies to reduce recurrence rates while preserving function in OPSCC patients. Her contributions are shaping the future of precision surgery in head and neck oncology, making her a pivotal figure in translating molecular targeting into real-time intraoperative guidance.